Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of HROWM will decline by -5.47% over the next 2 Weeks and hit $25.46 by Friday, November 24, 2023. In that time frame, HROWM's share price is expected to range between $25.18 and $25.73.
BearishAverageBullishHROWM shares rose +1.89% in Friday, August 8, 2025's trading session, rising from a previous close of $26.43 to move at $26.93. The stock demonstrated notable intraday movement (see HROWM's key stats for a full breakdown), fluctuating between $26.92 and $26.93, a +0.04% trading range. While recent weeks have seen some volatility, HROWM has managed to secure a +1.05% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 834 shares changing hands, 3.81K fewer than the previous session. This amounted to $22.46K in total market activity.
Will HROWM Continue Its Downward Trend?
According to analyst ratings and projections for HROWM, Harrow Health, Inc. 11.875% Senior Notes due 2027 shares are anticipated to decrease by -4.72%, potentially reaching $25.72 per share by November 24, 2023. Short-term technical indicators currently suggest a neutral sentiment for HROWM. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the HROWM stock forecast, now is not the best time to buy HROWM stock because its current trading price is +5.78% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on HROWM covering social and institutional perspectives.
HROWM Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into HROWM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 57.66% to 60.87%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 53.89%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.27%, maintains a neutral outlook for the long term. Insights into HROWM's shareholder base show how institutional investors are positioning themselves during these momentum shifts